-
Je něco špatně v tomto záznamu ?
Age- and dose-specific anticonvulsant action of bumetanide in immature rats
P. Mareš
Jazyk angličtina Země Česko
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- antikonvulziva farmakologie MeSH
- bumetanid farmakologie MeSH
- epilepsie tonicko-klonická chemicky indukované metabolismus prevence a kontrola MeSH
- financování organizované MeSH
- GABA metabolismus MeSH
- inhibitory Na-K-Cl symportérů farmakologie MeSH
- krysa rodu rattus MeSH
- modely nemocí na zvířatech MeSH
- pentylentetrazol MeSH
- potkani Wistar MeSH
- reakční čas MeSH
- sodík-draslík-chloridové symportéry metabolismus účinky léků MeSH
- stárnutí MeSH
- věkové faktory MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
GABA exhibits depolarizing action in the immature neurons due to high intracellular activity of chloride ions. It is maintained by cation-chloride cotransporter NKCC1 which is present in immature brain. Bumetanide is a specific inhibitor of this cotransporter. We studied possible anticonvulsant activity of bumetanide in pentylenetetrazol-induced seizures in three age groups of rat pups (7, 12, and 18 days old). Pretreatment with bumetanide (0.2-1 mg/kg i.p.) resulted in dose-dependent decrease of incidence of the tonic phase of generalized tonicclonic seizures in 12-day-old rats only. No effect was observed in younger and older animals. Higher dose of bumetanide (2.5 mg/kg) did not affect tonic convulsions but, on the contrary, decreased latencies of generalized seizures in 12-day-old animals. Lack of marked anticonvulsant effect is probably due to relative maturity of neurons in the brainstem where the generator of generalized seizures is localized. Age- and dosespecific suppression of the tonic phase needs further analysis.
Citace poskytuje Crossref.org
Lit.: 17
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10012610
- 003
- CZ-PrNML
- 005
- 20111210163243.0
- 008
- 100526s2009 xr e eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.931897 $2 doi
- 035 __
- $a (PubMed)20059292
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Mareš, Pavel, $d 1937- $7 jo20000074131
- 245 10
- $a Age- and dose-specific anticonvulsant action of bumetanide in immature rats / $c P. Mareš
- 314 __
- $a Department of Developmental Epileptology, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague
- 504 __
- $a Lit.: 17
- 520 9_
- $a GABA exhibits depolarizing action in the immature neurons due to high intracellular activity of chloride ions. It is maintained by cation-chloride cotransporter NKCC1 which is present in immature brain. Bumetanide is a specific inhibitor of this cotransporter. We studied possible anticonvulsant activity of bumetanide in pentylenetetrazol-induced seizures in three age groups of rat pups (7, 12, and 18 days old). Pretreatment with bumetanide (0.2-1 mg/kg i.p.) resulted in dose-dependent decrease of incidence of the tonic phase of generalized tonicclonic seizures in 12-day-old rats only. No effect was observed in younger and older animals. Higher dose of bumetanide (2.5 mg/kg) did not affect tonic convulsions but, on the contrary, decreased latencies of generalized seizures in 12-day-old animals. Lack of marked anticonvulsant effect is probably due to relative maturity of neurons in the brainstem where the generator of generalized seizures is localized. Age- and dosespecific suppression of the tonic phase needs further analysis.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a věkové faktory $7 D000367
- 650 _2
- $a stárnutí $7 D000375
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antikonvulziva $x farmakologie $7 D000927
- 650 _2
- $a bumetanid $x farmakologie $7 D002034
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a epilepsie tonicko-klonická $x chemicky indukované $x metabolismus $x prevence a kontrola $7 D004830
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a pentylentetrazol $7 D010433
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a reakční čas $7 D011930
- 650 _2
- $a inhibitory Na-K-Cl symportérů $x farmakologie $7 D049994
- 650 _2
- $a sodík-draslík-chloridové symportéry $x metabolismus $x účinky léků $7 D028021
- 650 _2
- $a GABA $x metabolismus $7 D005680
- 773 0_
- $w MED00003824 $t Physiological research $g Roč. 58, č. 6 (2009), s. 927-930 $x 0862-8408
- 856 41
- $u http://www.biomed.cas.cz/physiolres/pdf/58/58_927.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 8
- 990 __
- $a 20100525095435 $b ABA008
- 991 __
- $a 20100603153033 $b ABA008
- 999 __
- $a ok $b bmc $g 726467 $s 589621
- BAS __
- $a 3
- BMC __
- $a 2009 $b 58 $c 6 $m Physiological research $x MED00003824 $d 927-930
- LZP __
- $a 2010-28/ipme